Helicobacter pylori neutrophil-activating protein: from molecular pathogenesis to clinical applications.
about
High yield purification of Helicobacter pylori neutrophil-activating protein overexpressed in Escherichia coliDifferential effects of DEAE negative mode chromatography and gel-filtration chromatography on the charge status of Helicobacter pylori neutrophil-activating protein.Helicobacter pylori neutrophil-activating protein induces release of histamine and interleukin-6 through G protein-mediated MAPKs and PI3K/Akt pathways in HMC-1 cells.Serum Cytokine Signature That Discriminates Helicobacter pylori Positive and Negative Juvenile Gastroduodenitis.Linkages between oral commensal bacteria and atherosclerotic plaques in coronary artery disease patients.Serum Antibodies against Helicobacter pylori Neutrophil Activating Protein in Carriers of IL-4 C-590T Genetic Polymorphism Amplify the Risk of Gastritis and Gastric Cancer.The study of H. pylori putative candidate factors for single- and multi-component vaccine development.Systemic and mucosal pre-administration of recombinant Helicobacter pylori neutrophil-activating protein prevents ovalbumin-induced allergic asthma in mice.Comparison of Iron-Binding Ability Between Thr70-NapA and Ser70-NapA of Helicobacter pylori.Dps from Deinococcus radiodurans: oligomeric forms of Dps1 with distinct cellular functions and Dps2 involved in metal storage.Serum Antibodies against Helicobacter pylori Neutrophil Activating Protein in Carriers of IL-4 C-590T Genetic Polymorphism Amplify the Risk of Gastritis and Gastric Cancer.One-step Negative Chromatographic Purification of Helicobacter pylori Neutrophil-activating Protein Overexpressed in Escherichia coli in Batch Mode.Production and delivery of Helicobacter pylori NapA in Lactococcus lactis and its protective efficacy and immune modulatory activity.What Roles Do Probiotics Play in the Eradication of ? Current Knowledge and Ongoing ResearchComparative proteomics of two Mycoplasma hyopneumoniae strains and Mycoplasma flocculare identified potential porcine enzootic pneumonia determinants
P2860
Q28647787-0B37A6AC-C791-4AB7-9D06-7FE9B225D15EQ36318284-6A85D176-D5BC-46B3-A4B2-C415FB91EDC4Q36782166-B2E55C78-0E7E-40C2-AB2E-BDBA4250C808Q37503880-3E1725E2-087D-4D65-879C-DB20060FF5A9Q38709537-A916C8CB-B4C7-4334-BD9A-46D5E006925DQ39346273-C0BBD8CE-4734-41D3-8ED8-01DA512DB60CQ39350897-99D7585D-79AC-45F5-9D26-8FC13961274AQ40372154-665EC224-2122-4E19-B88D-C21254CD6B44Q41011366-95E1E33F-2E6C-43F7-B3DE-FC1AAD25CED7Q46682116-87A614E8-FF37-4634-9CD5-027A11768B1BQ47099523-B4B67656-0B58-4508-A954-83A2B7561B73Q51647134-A531C758-0315-4393-ABEA-281623B139B4Q54228847-496F073A-776F-4A0F-B30F-1267F392482DQ58554627-BAC07566-2CDE-4E7A-A30A-4BC9EEBB80BAQ58787933-5621C83C-F153-4071-9779-4776ACD5494A
P2860
Helicobacter pylori neutrophil-activating protein: from molecular pathogenesis to clinical applications.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Helicobacter pylori neutrophil ...... esis to clinical applications.
@ast
Helicobacter pylori neutrophil ...... esis to clinical applications.
@en
type
label
Helicobacter pylori neutrophil ...... esis to clinical applications.
@ast
Helicobacter pylori neutrophil ...... esis to clinical applications.
@en
prefLabel
Helicobacter pylori neutrophil ...... esis to clinical applications.
@ast
Helicobacter pylori neutrophil ...... esis to clinical applications.
@en
P2860
P356
P1476
Helicobacter pylori neutrophil ...... esis to clinical applications.
@en
P2860
P304
P356
10.3748/WJG.V20.I18.5294
P407
P50
P577
2014-05-01T00:00:00Z